Internal Medicine, Nephrology · Los Angeles, CA
NPI
1003924168
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
5901 W Olympic Blvd, Suite 307
Los Angeles, CA, 90036
Phone (323) 939-3669
Groups this clinician bills Medicare through
Medicare paid, 2024
$517K
4,610 services
Medicare patients, 2024
619
Average age 76
Drug cost, 2024
$227K
2,021 prescriptions
Company payments, 2025
$51.41
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alfred Rahban was code 99233 (hospital e&m - subsequent), 2,018 times for 516 patients. In total Alfred Rahban billed 4,610 services in 21 codes, and Medicare paid $517K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-02-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 2,018 | 516 | $105.34 | $213K |
| 99232 Hospital E&M - Subsequent | Facility | 1,253 | 216 | $70.10 | $88K |
| 99223 Hospital E&M - Initial | Facility | 397 | 294 | $154.18 | $61K |
| 90960 ESRD Related Services (not dialysis) | Office | 210 | 30 | $316.91 | $67K |
| 90935 Hemodialysis | Facility | 147 | 30 | $62.98 | $9,258 |
| 99214 Office E&M - Established | Office | 118 | 50 | $113.71 | $13K |
| 99291 Critical Care E&M | Facility | 104 | 27 | $187.34 | $19K |
| 99239 Hospital Discharge Management | Facility | 87 | 65 | $102.99 | $8,960 |
| 99310 SNF E&M | Facility | 69 | 12 | $135.54 | $9,353 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 61 | 16 | $28.59 | $1,744 |
| 90961 ESRD Related Services (not dialysis) | Office | 41 | 21 | $254.62 | $10K |
| 99497 Care Management/Coordination | Facility | 28 | 28 | $67.50 | $1,890 |
| 99215 Office E&M - Established | Office | 19 | 16 | $153.18 | $2,910 |
| 99306 SNF E&M | Facility | 17 | 13 | $163.90 | $2,786 |
| 90962 ESRD Related Services (not dialysis) | Office | 14 | 12 | $184.18 | $2,579 |
By year: 2022 $485K for 4,899 services; 2023 $496K for 4,783 services; 2024 $517K for 4,610 services.
Medicare prescription drug claims, 2024
In 2024, the drug Alfred Rahban prescribed most often to Medicare patients was Atorvastatin Calcium, with 101 prescriptions and refills. In total Alfred Rahban wrote 2,021 Medicare prescriptions that cost $227K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 101 | 147 | 21 | $670 |
| Amlodipine Besylate Generic | 100 | 172 | 23 | $575 |
| Eliquis Apixaban | 64 | 70 | 12 | $36K |
| Furosemide Generic | 61 | 119 | 20 | $446 |
| Gabapentin Generic | 61 | 84 | 14 | $676 |
| Pantoprazole Sodium Generic | 52 | 68 | Under 11 | $1,396 |
| Levothyroxine Sodium Generic | 41 | 57 | Under 11 | $214 |
| Chlorthalidone Generic | 38 | 47 | Under 11 | $287 |
| Tamsulosin Hcl Generic | 37 | 45 | Under 11 | $384 |
| Ozempic Semaglutide | 36 | 36 | Under 11 | $34K |
| Calcium Acetate Generic | 34 | 40 | Under 11 | $1,938 |
| Metoclopramide Hcl Generic | 34 | 40 | Under 11 | $252 |
| Ondansetron Hcl Generic | 33 | 33 | Under 11 | $591 |
| Metoprolol Tartrate Generic | 32 | 46 | Under 11 | $282 |
| Famotidine Generic | 30 | 47 | Under 11 | $258 |
Brand drugs: - claims; generic drugs: 1,720 claims; opioid claims: 45.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alfred Rahban $51.41 ($51.41 in general payments such as food, travel and fees) from 1 company. The largest payer was Akebia Therapeutics Inc with $51.41.
| Company | Payments | Amount |
|---|---|---|
| Akebia Therapeutics Inc AKBA | 1 | $51.41 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.